Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
03/2005
03/16/2005EP1513839A1 3-substituted quinuclidines and their use
03/16/2005EP1513837A1 Thiazole derivatives as phosphodiesterase iv inhibitors
03/16/2005EP1513836A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
03/16/2005EP1513835A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
03/16/2005EP1513831A1 Novel compounds, their use and preparation
03/16/2005EP1513830A1 Bisindolyl-maleimid derivatives as kinase inhibitors
03/16/2005EP1513827A1 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors
03/16/2005EP1513826A1 New indolylpiperidine derivatives as potent antihistaminic and antiallergic agents
03/16/2005EP1513810A1 4-(aryl or heteroaryl) -2-butylamine derivatives and their use as glucocorticoid ligans
03/16/2005EP1513808A2 Fluorinated cyclic amides as dipeptidyl peptidase iv inhibitors
03/16/2005EP1513803A1 Ligands that are inhibitors of the rar receptors
03/16/2005EP1513589A1 1,5-disubstituted pyrrolid-2-one derivatives for use as ep4 receptor agonists in the treatment of eye diseases such as glaucoma
03/16/2005EP1513543A2 Fas peptide mimetics and uses thereof
03/16/2005EP1513536A1 Use of compounds that stimulate cgmp
03/16/2005EP1513523A1 1,5-disubstituted imidazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of eye and bone diseases
03/16/2005EP1513522A2 Methods of treating conditions associated with an edg receptor
03/16/2005EP1513521A2 Pyranoindazoles and their use for the treatment of glaucoma
03/16/2005EP1513520A2 Substituted pyrrolines as kinase inhibitors
03/16/2005EP1513494A2 Film-shaped mucoadhesive administration form for administering cannabis active ingredients
03/16/2005EP1513493A2 Analgesics
03/16/2005EP1513419A2 Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
03/16/2005EP1351962B1 Thienopyrimidine
03/16/2005EP1233959B1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
03/16/2005EP1226119B1 Tyrosine kinase inhibitors
03/16/2005EP1140900B1 Pyrazole compounds and uses thereof
03/16/2005EP1135134B1 Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases
03/16/2005EP1117296B1 Combination of bisphosphonate and tetracycline
03/16/2005EP1096975B1 Use of a3 adenosine receptor antagonists in the manufacture of a medicament for reducing intraocular pressure
03/16/2005CN1596253A Spiro-hydantoin compounds useful as anti-inflammatory agents
03/16/2005CN1596240A Chalcone derivatives and their use to treat diseases
03/16/2005CN1596127A Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound
03/16/2005CN1596115A Treatment of hyperproliferative diseases using active vitamin D analogues
03/16/2005CN1593651A Novel usage of human antalzyme in the process for preparing ophthalmopathy treating medicine
03/16/2005CN1593612A Fumigant with eyes enriching, vision promoting, asthenopia relieving function
03/16/2005CN1593611A Nutrient food with eyes enriching and vision promoting function
03/16/2005CN1593420A Ginkoleaf extract and diphyridamole powder injection and its preparation
03/16/2005CN1193026C Z-pyrazoline-5-ones
03/16/2005CN1193025C Novel 1, 3-dihydro-2H-indol-2-one derivatives, their preparing method and pharmceutical composition containing the same
03/16/2005CN1193000C Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cometic compositions containing same
03/16/2005CN1192798C Vaccine
03/15/2005US6867222 Nociceptin analogs
03/15/2005US6867220 Phenoxypropanolamines, method for producing them and pharmaceutical compositions containing them
03/15/2005US6867213 Vitronectin receptor inhibitors; bone diseases, osteoporosis; esterification of acid form with isopropanol
03/15/2005US6867210 For treatment or prevention of neurodegenerative conditions such as amyotrophic lateral sclerosis, acute or chronic pain, as antitinnitus agents, anticonvulsants, antimanic depressants, local anesthetics, antiarrhythmics
03/15/2005US6867208 Vitronectin receptor antagonists, their preparation and their use
03/15/2005CA2323047C Prodrugs of benzofuranylmethyl carbamate nk, antagonists
03/15/2005CA2246595C Novel atropisomers of 2,3-disubstituted-(5,6)-heteroarylfused-pyrimidin-4-ones
03/10/2005WO2005021776A2 METHODS OF USING MAMMALIAN RNase H AND COMPOSITIONS THEREOF
03/10/2005WO2004012733A9 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy
03/10/2005WO2004003166A3 Antibodies and uses thereof
03/10/2005WO2003104260A3 Pharmaceutical formulation
03/10/2005WO2003085089A3 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
03/10/2005WO2001066772A9 Heparinase iii and uses thereof
03/10/2005US20050054729 Combined with a statin, ACE-inhibitor, PDE V-inhibitor, Ca-antagonist, beta-blocker, arginine, or tetrahydrobiopterin; treating of conditions including cardiovascular disorders, erectile dysfunction, therapy and prophylaxis of diabetes including its complicatons, and respiratory diseases
03/10/2005US20050054723 Administration to the individual of a prostaglandin analogue selective for the EP2 prostanoid receptor in combination with an alpha-adrenergic agonist
03/10/2005US20050054706 N-substituted pyrroles, pyrazoles, imidazoles, triazoles and tetrazoles used for treating and preventing cancer, inflammation, autoimmune diseases, respiratory system disorders, septic shock, pain, preterm labor, as dietetics and sexual disorders, and disorders associated with MAP kinases
03/10/2005US20050054699 Skin disorders; vision defects; glandular disorders
03/10/2005US20050054689 prostaglandin derivatives such as (Z)-7-((1R,2S,3R)-2-Butylcarbamoyloxymethyl-3-hydroxy-5-oxo-cyclopentyl)-hept-5-enoic acid methyl ester, administering to mammals for treatment of ocular hypertension; hypotensive agents
03/10/2005US20050054641 Propanolaminomethyltetralines, their preparation and pharmaceutical composition comprising same
03/10/2005US20050054623 Transdermal supplying testosterone gel
03/10/2005US20050054593 New drug
03/10/2005US20050054586 Using cloricromene , or hydrochloride thereof
03/10/2005US20050054036 Growth factor isoform
03/10/2005US20050053599 Antagonist for endothelial growth agents for treatment of edema and for kidney dialysis
03/10/2005CA2536184A1 Use of bisphosphonates for otosclerosis
03/09/2005EP1512400A1 Treatment of neurodegenerative diseases
03/09/2005EP1511765A1 Par-2-activating peptide derivative and pharmaceutical composition using the same
03/09/2005EP1511744A2 Bis-benzimidazoles and related compounds as potassium channel modulators
03/09/2005EP1511743A1 Pyrazole-derivatives as p38 kinase inhibitors
03/09/2005EP1511742A1 Kinase inhibitors
03/09/2005EP1511737A1 Aryloximes
03/09/2005EP1511736A1 Therapeutic molecules and methods-1
03/09/2005EP1511728A2 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics
03/09/2005EP1511722A1 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof
03/09/2005EP1511719A1 Amide derivatives as inhibitors of the enzymatic activity of renin
03/09/2005EP1511716A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
03/09/2005EP1511516A1 Topically applicable pharmaceutical preparation
03/09/2005EP1511507A1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
03/09/2005EP1511499A2 Immunomodulatory compounds and methods of use thereof
03/09/2005EP1511484A1 Combination of a dpp iv inhibitor and a cardiovascular compound
03/09/2005EP1511482A1 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections
03/09/2005EP1511481A1 Ophthalmological use of roflumilast for the treatment of diseases of the eye
03/09/2005EP1511473A2 Bis-aromatic alkanols
03/09/2005EP1126849B1 Heterocyclic potassium channel inhibitors
03/09/2005CN1592782A Adipose tissue-derived stromal cells for the repair of corneal and intra-orbital defects and uses thereof
03/09/2005CN1592747A Diazabicyclo alkane derivatives with NK1 antagonistic activity
03/09/2005CN1592744A Thiazole derivatives having CB1-antagonistic, agonistic or partial agonistic activity
03/09/2005CN1592619A Pyranoindazoles and their use for the treatment of glaucoma
03/09/2005CN1592615A Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes
03/09/2005CN1590379A New heterocyclic oxime compounds, preparing process and medical composition thereof
03/09/2005CN1589907A Controlled release medicine for ophthalmic disease
03/09/2005CN1589889A Extract of plant dendrobii caulis and preparing process and use thereof
03/09/2005CN1589851A External use traditional Chinese medicine for treating tympanitis
03/09/2005CN1589795A Nimodiping Freeze dried composition and its preparation method
03/09/2005CN1589791A Application of haematopophyrin in treating ophthalmic disease
03/09/2005CN1192032C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
03/09/2005CN1191860C Method for treatment of fibrosis using antagonist of integrin alpha-4 subunit
03/09/2005CN1191852C Vaccine
03/09/2005CN1191827C Tanrine derivatives usable in treatment of ophthamic disorders
03/08/2005US6864383 Ophthalmic compositions for treating ocular hypertension
1 ... 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 ... 531